VEST Vestiage Inc (PK)

Vestiage™, Inc. (“VEST”), the healthy-aging company, announced today that they will be featured as an undiscovered Wall Street opportunity and pick of the week on ‘Under The Radar Minute,’ a radio segment airing on financial news networks on satellite radio. Uncovering emerging stock market investment opportunities, ‘Under The Radar’ identifies those companies with incredible upside potential and provides information on those publicly traded companies before they gain the widespread attention of Wall Street.

Airing during the open and close of the market nationally on satellite radio to the full subscriber base, the segment says that Vestiage is experiencing exponential growth in both its revenue verticals. On August 14th the Company announced 2nd quarter financial results including Direct Response revenue, up 183%, overall company revenue growth up 74% and growth margin expansion up from 49% to 69%. The segment also opined that with the Company’s growth in overall revenue and demonstrated confidence from national retailers, Vestiage, Inc, stock symbol VEST, is undervalued within the growth capacity matrix and offers incredible potential as Wall Street recognition continues to increase.

Scott Kimball, CEO of Vestiage, Inc. stated, “We’re pleased to be featured on ‘Under The Radar,’ and look forward to continued awareness from investors as we grow.”

More information on the upside potential of the Vestiage stock can be found at the Under The Radar website, www.undertheradarminute.com, or at the Company website, www.Vestiage.com.

About Vestiage™

Vestiage™ (stock symbol "VEST") is a publicly traded healthy aging company that creates and acquires emerging healthy aging brands. Vestiage™ brands address the top “in demand” healthy aging concerns of men and women. The Company offers branded science-based nutraceuticals to a strong demographic consumer base through multiple channels. Vestiage is focused on the use of the best ingredients from the ocean and earth, including cutting edge, patented, clinically proven ingredients to produce highly potent, and elegantly formulated products. Using potency and novel ingredient combinations, Vestiage™ creates and distributes nutraceuticals such as RegiMEN for men (www.RegimenLife.com) and the multifunctional Monterey Bay Nutraceuticals line for women (www.MontereyBayNutra.com). Vestiage™ research is focused on extending the active period of a human life covering both the cognitive and physical realms. To learn more, visit the Company website, www.vestiage.com.

As with many fast growing companies, our growth is dependent upon adequate funding for inventory, media, general overhead, professional fees, technology, salaries and other expenses related to the business. Should we be unable in the future to obtain appropriate funding to pay our expenses and media at current levels, our growth, and our financial stability, will be negatively impacted.

This Press Release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to our financial condition, results of operations and business. These forward looking statements can be identified by the use of terms such as "believe," "expects," "plan," "intend," "may," "will," "should," "can," or "anticipates," or the negative thereof, or variations thereon, or comparable terminology, or by discussions of strategy. These statements involve known and unknown risks, uncertainties and other factors that may cause industry trends or our actual results to be materially different from any future results expressed or implied by these statements. Important factors that may cause our results to differ from these forward-looking statements include, but are not limited to: (i) changes in or new government regulations or increased enforcement of the same, (ii) unavailability of desirable acquisitions or inability to complete them, (iii) increased costs, including from increased raw material or energy prices, (iv) changes in general worldwide economic or political conditions, (v) adverse publicity or negative consumer perception regarding nutritional supplements, anti-aging or stem cell facial care products or stem cell technology in general, (vi) issues with obtaining raw materials of adequate quality or quantity, (vii) litigation and claims, including product liability, intellectual property and other types, (viii) disruptions from or following acquisitions including the loss of customers, (ix) increased competition, (x) slow or negative growth in the anti-aging or cosmetics, beauty, or nutritional supplement industry or the healthy foods or anti-aging channel, (xi) the loss of key personnel or the inability to manage our operations efficiently, (xii) problems with information management systems, manufacturing efficiencies and operations, (xiii) insurance coverage issues, (xiv) the volatility of the stock market generally and of our stock specifically, (xv) increases in the cost of borrowings or unavailability of additional debt or equity capital, or both, or fluctuations in foreign currencies, and (xvi) interruption of business or negative impact on sales and earnings due to acts of God, acts of war, terrorism, bio-terrorism, civil unrest and other factors outside of our control.

VestiageScott Kimball, CEO949-258-4404ir@vestiageinc.com

Vestiage (PK) (USOTC:VEST)
Gráfico Histórico do Ativo
De Out 2024 até Nov 2024

Vestiage (PK) (USOTC:VEST)
Gráfico Histórico do Ativo
De Nov 2023 até Nov 2024